home / stock / saga / saga news

SAGA News and Press, Sagaliam Acquisition Corp. From 09/15/23

Stock Information
Company Name: Sagaliam Acquisition Corp.
Stock Symbol: SAGA
Market: NASDAQ
Menu
SAGA SAGA Quote SAGA Short SAGA News SAGA Articles SAGA Message Board
Get SAGA Alerts

News, Short Squeeze, Breakout and More Instantly...
SAGA - SAGALIAM ACQUISITION CORP. ANNOUNCES EXECUTION OF DEFINITIVE BUSINESS COMBINATION AGREEMENT AND RECEIPT OF NASDAQ LISTING DELINQUENCY LETTER

New York, NY, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: “SAGAU”, “SAGA”, “SAGAR”) (“ we ”, “ us ”, “ our ”, or the “ Compan y”) announced today that it re...
SAGA - Virogentics, Inc. Receives Permit for Export to Africa of the ITV-1 Immunotherapy Solidifying the Scheduled Administration of the Treatment

Reports on Business combination agreement progress ALLEN, TX / ACCESSWIRE / August 8, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com/ ). Virogentics, Inc. ("VIRO") a wholly owned subsidiary of Enzolytics, Inc. (the "Company" or "ENZC"), a drug development biotech company, ...

SAGA - SAGALIAM ACQUISITION CORP. ANNOUNCES RECEIPT OF NASDAQ LISTING DELINQUENCY LETTER AND APPOINTMENT OF INDEPENDENT DIRECTORS

New York, NY, July 28, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: “SAGAU”, “SAGA”, “SAGAR”) (“ we ”, “ us ”, “ our ”, or the “ Compan y”) announced today that it rec...

SAGA - SPAC Sagaliam, Enzolytics agree to raise price of unit sale to $450M

2023-06-30 14:52:07 ET SPAC Sagaliam Acquisition Corp. ( NASDAQ: SAGA ) said it has agreed to raise the combined purchase price of Enzolytics' ( OTCPK:ENZC ) Biogenysis and Virogentics units to $450M from $250M. Sagaliam and Enzolytics said that terms of the non-binding term...
SAGA - Sagaliam Acquisition Corp. Announces Amendment to Non-Binding Term Sheet with Enzolytics Inc. and Addition of New Board Members

NEW YORK, NY / ACCESSWIRE / June 30, 2023 / Sagaliam Acquisition Corp. (NASDAQ:"SAGAU", "SAGA", "SAGAR") (" we ", " us ", " our ", or the " Compan y") announced today that it has amended the executed non-binding term sheet for the purchase of Biogenysis, Inc. ("BGEN") and Virogentics Inc. ("VIRO...

SAGA - Sagaliam Acquisition regains compliance with Nasdaq

2023-06-05 07:03:03 ET Sagaliam Acquisition ( NASDAQ: SAGA ) has received a notification letter from Nasdaq confirming the company has regained compliance with Nasdaq's listing rule. Nasdaq had earlier notified the company is not in compliance, as...

SAGA - SAGALIAM ACQUISITION CORP. REGAINS COMPLIANCE WITH NASDAQ LISTING RULE 5250(C)(1)

New York, NY, June 02, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: “SAGAU”, “SAGA”, “SAGAR”) (“ we ”, “ us ”, “ our ”, or the “ Compan y”) announced today that it rec...
SAGA - SAGALIAM ACQUISITION CORP. ANNOUNCES RESIGNATION OF THOMAS W. NEUKRANZ AS CHIEF FINANCIAL OFFICER AND DIRECTOR

New York, NY, May 11, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: “SAGAU”, “SAGA”, “SAGAR”) (“ we ”, “ us ”, “ our ”, or the “ Compan y”) announced today that Thomas ...

SAGA - SAGALIAM ACQUISITION CORP. ANNOUNCES RECEIPT OF NASDAQ LISTING DELINQUENCY LETTER

New York, NY, April 21, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: “SAGAU”, “SAGA”, “SAGAR”) (“ we ”, “ us ”, “ our ”, or the “ Compan y”) announced today that it re...

SAGA - SAGALIAM ACQUISITION CORP. CONFIRMS FUNDING AND EXTENSION OF DEADLINE TO COMPLETE BUSINESS COMBINATION

New York, NY, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: “SAGAU”, “SAGA”, “SAGAR”) (“ we ”, “ us ”, “ our ”, or the “ Compan y”) announced today that it was...
Previous 10 Next 10